Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Filings indexed 2,288 across all filing types
Latest filing 2023-05-29 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
辽宁成大股份有限公司关于召开2022年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2022 Annual General Meeting (AGM) of 辽宁成大股份有限公司, including details such as the date, voting methods, agenda items, and proxy forms. It does not contain the actual annual report or financial statements but rather informs shareholders about the meeting and the matters to be voted on, including the 2022 annual report and financial results. The document length is 3689 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document is best classified as AGM Information (AGM-R).
2023-05-29 Chinese
辽宁成大股份有限公司关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the progress of the company's share repurchase program, detailing the number of shares repurchased, prices, and total funds used. It references previous announcements and regulatory compliance related to share buybacks. The content focuses on the update of the share repurchase activity rather than financial results or other report types. The document length is 1859 characters, which is relatively short and typical for a progress announcement. Therefore, this fits the category of a Transaction in Own Shares (POS) filing, which covers company buyback or sale of its own shares.
2023-05-21 Chinese
辽宁成大股份有限公司关于召开2022年度业绩暨现金分红说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about a scheduled investor meeting to discuss the 2022 annual performance and cash dividend. It specifies the date, time, location, and format of the meeting, and invites investors to participate and ask questions. The document references the previously published 2022 annual report but does not contain the report itself or detailed financial data. The document is short (1512 characters) and serves as a notice for the upcoming event rather than the event content or report. Therefore, it is best classified as an Investor Presentation (IP) since it is a detailed presentation for investors focusing on financials, strategy, and market position, specifically an investor meeting announcement with interactive Q&A.
2023-05-19 Chinese
辽宁成大股份有限公司关于公司定向债务融资工具获准注册的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the approval and registration of a company's directed debt financing instrument. It mentions the registration notice from the China Interbank Market Dealers Association and details about the debt financing tool amount and validity period. There is no financial report or detailed financial data presented, only an update on financing activity. This fits the category of Capital/Financing Update (CAP). The document length is short and focused on financing registration, not a full report or announcement of voting results or management changes.
2023-05-08 Chinese
辽宁成大股份有限公司关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the progress of the company's share repurchase program, detailing the number of shares repurchased, prices, and total funds used. It references previous announcements and regulatory rules about share buybacks. The content focuses on the company's own shares repurchase activity and does not contain financial statements or earnings data. The document length is short (1941 characters) and it is a progress update on share repurchase, which fits the category of Transaction in Own Shares (POS).
2023-05-04 Chinese
辽宁成大股份有限公司2023年第一季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled '2023 年第一季度报告' which translates to '2023 First Quarter Report'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2023. The report is unaudited as indicated. The length is substantial (15,000 characters) and it contains actual financial statements and analysis for a period shorter than a full fiscal year, specifically a quarter. This matches the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, and it is not a full annual report or other filing type. Therefore, the correct classification is IR with high confidence. Q1 2023
2023-04-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.